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Background:  Rapid diagnosis of ACS in the Emergency Department (ED) enhances clinical care and is an operational priority. We examined the 
diagnostic performance of an investigational troponin (Tn) assay with 10-100x greater analytical sensitivity than current commercial assays.
Methods:  We enrolled pts (N=403) with non-traumatic chest pain in the BWH-TIMI ED Chest Pain Study. TnI was measured at baseline, 4-6h, & 
12-24h with the investigational assay (S-TnI; Singulex, Detection-limit: 0.0002 ug/L, 99th %ile : 0.009 ug/L). Final dx was CEC adjudicated using all 
diagnostic data and a conventional assay for cTnI (Siemens), blinded to S-TnI.
Results:  The adj dx was MI in 102 pts, unstable angina (UA) in 49, and acute non-coronary CV conditions (NCCV) in 59. Sensitivity (97%) was 
significantly higher with baseline S-TnI (Fig A) with specificity and PPV of 80% (95%CI: 75% - 84%) & 62% (54% - 70%). The NPV for MI with S-TnI 
was 99% (96-100%). Of the 60 pts with a final dx other than MI and elevated S-TnI, 14 (23%) had UA, 18 (30%) NCCV, 5 (8%) stable angina, and 23 
(38%) non-cardiac pain. Among 20 pts with a negative baseline conventional TnI and final dx of MI, 19 had an elevated S-TnI at baseline. The AUC for 
MI was 0.973 for S-TnI vs. 0.912 for conventional TnI (Fig B, p= 0.0047).
Conclusion: A new, more sensitive Tn assay substantially increased early clinical sensitivity and improved diagnostic accuracy, 
despite an expected decline in clinical specificity for MI. Of those with positive S-TnI without MI, 61% had acute CV processes. 
